PRINCIPAL FINANCIAL GROUP INC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 163 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$62,000
-95.7%
48,301
-95.8%
0.00%
-100.0%
Q4 2021$1,445,000
-43.9%
1,138,160
-3.6%
0.00%
-50.0%
Q3 2021$2,575,000
-41.6%
1,180,984
+0.5%
0.00%
-33.3%
Q2 2021$4,407,000
+28.7%
1,175,172
+11.9%
0.00%
+50.0%
Q1 2021$3,423,000
-2.9%
1,050,078
+1.6%
0.00%
-33.3%
Q4 2020$3,526,000
-19.7%
1,033,923
-3.9%
0.00%
-25.0%
Q3 2020$4,391,000
+45.2%
1,076,210
+20.3%
0.00%
+33.3%
Q2 2020$3,024,000
+46.3%
894,695
+0.8%
0.00%
+50.0%
Q1 2020$2,067,000
-38.5%
887,329
-3.9%
0.00%
-33.3%
Q4 2019$3,360,000
-56.1%
923,116
+0.0%
0.00%
-57.1%
Q3 2019$7,657,000
+0.6%
923,014
+4.5%
0.01%0.0%
Q2 2019$7,608,000
-18.9%
883,603
+0.7%
0.01%
-22.2%
Q1 2019$9,380,000
+25.6%
877,436
+2.8%
0.01%
+12.5%
Q4 2018$7,466,000
-46.6%
853,294
+2.5%
0.01%
-33.3%
Q3 2018$13,981,000
-12.1%
832,214
+9.6%
0.01%
-20.0%
Q2 2018$15,909,000
+37.1%
759,004
+5.2%
0.02%
+36.4%
Q1 2018$11,606,000
-12.8%
721,337
+2.7%
0.01%
-8.3%
Q4 2017$13,309,000
+61.4%
702,317
+19.8%
0.01%
+50.0%
Q3 2017$8,247,000
+100.3%
586,141
+6.0%
0.01%
+100.0%
Q2 2017$4,118,000
+14.5%
552,868
-0.1%
0.00%0.0%
Q1 2017$3,598,000
+53.5%
553,451
+4.6%
0.00%
+33.3%
Q4 2016$2,344,000
-4.2%
529,206
+1.0%
0.00%0.0%
Q3 2016$2,447,000
-15.3%
523,950
+19.1%
0.00%
-25.0%
Q2 2016$2,890,000
+8.8%
439,980
+5.3%
0.00%0.0%
Q1 2016$2,657,000
+9.7%
417,723
+4.0%
0.00%0.0%
Q4 2015$2,421,000
+5.4%
401,545
+4.5%
0.00%0.0%
Q3 2015$2,298,000
-10.8%
384,219
+1.9%
0.00%0.0%
Q2 2015$2,577,000
+12.5%
376,883
-0.0%
0.00%
+33.3%
Q1 2015$2,290,000
-10.0%
377,042
+2.7%
0.00%
-25.0%
Q4 2014$2,544,000
-15.4%
367,114
-0.7%
0.00%
-20.0%
Q3 2014$3,008,000
+3.7%
369,563
+3.5%
0.01%0.0%
Q2 2014$2,902,000
+5.9%
356,911
+2.2%
0.01%0.0%
Q1 2014$2,740,000
-6.3%
349,377
+5.7%
0.01%0.0%
Q4 2013$2,924,000
+13.4%
330,411
+7.5%
0.01%0.0%
Q3 2013$2,579,000
+17.9%
307,396
+4.8%
0.01%0.0%
Q2 2013$2,187,000293,1810.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders